A61K 45 - Medicinal preparations containing active ingredients not provided for in groups

Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
11/2006
11/14/2006	US7135305 Methods for controlling the lysis of coagulated blood with apolipoprotein e4 phenotype
11/14/2006	US7135301 Detection and treatment of prostate cancer
11/14/2006	US7135280 Assay to determine efficacy of treatment for mycobacterial infection
11/14/2006	US7135195 Colorless antimicrobioal aqueous suspension of colloidal silver particles having an interior of elemental silver and a surface of silver oxide of given particle diameters; antiseptic and surface disinfectant and for treatment of viral, fungal, and bacterial infections
11/14/2006	US7135192 Lipid, Dna complex with detectable labels
11/14/2006	US7135190 Biodegradable and water soluble polyesterether block polymers possessing reverse thermal gelation properties, used for drug delivery of genes, peptides, anticancer or antiproliferative agents
11/14/2006	US7135189 Compositions and techniques for localized therapy
11/14/2006	US7135170 Methods for treating viral infection using IL-28 and IL-29
11/14/2006	CA2340320C Use of an angiogenic factor for the treatment of microascular angiopathies
11/14/2006	CA2308873C Use of at least one inhibitor of at least one calcium channel in wrinkle treatment
11/14/2006	CA2228049C Two-phase preparation
11/13/2006	CA2790058A1 Herceptin® adjuvant therapy
11/13/2006	CA2540547A1 Herceptin adjuvant therapy
11/09/2006	WO2006119507A2 Non-nucleotide composition and method for inhibiting platelet aggregation
11/09/2006	WO2006118329A1 Stable emulsion composition
11/09/2006	WO2006118328A1 Degranulation inhibitor
11/09/2006	WO2006118313A1 Novel polypeptide and use thereof
11/09/2006	WO2006118289A1 Method for identification of compound having antidepressant effect
11/09/2006	WO2006118278A1 Temperature-sensitive liposome and temperature-sensitive drug release system
11/09/2006	WO2006118268A1 Therapeutic agent for chronic obstructive pulmonary disease
11/09/2006	WO2006118265A1 Composition containing antidementia agent
11/09/2006	WO2006118212A1 Agent for preventing and treating pancreatitis
11/09/2006	WO2006118169A1 Antiasthmatic drug comprising pgd2 receptor antagonist and leukotriene receptor antagonist
11/09/2006	WO2006118085A1 Agent for promoting hepatic cell replication and agent for improving insulin resistance
11/09/2006	WO2006117991A1 Promoter for introducing extracellular substance into mammalian ovum and introduction method
11/09/2006	WO2006117881A1 Active foam
11/09/2006	WO2006117405A1 The use of free radical scavengers for protecting and treating skin and hair damages caused by chemotherapy
11/09/2006	WO2006117221A1 Use of azapaullones for preventing and treating pancreatic autoimmune disorders
11/09/2006	WO2005120524A3 Nutritional formulations
11/09/2006	WO2005097087A3 Merged ion channel modulating compounds and uses thereof
11/09/2006	WO2005074989A3 Combination of a dna topoisomerase inhibitor and an iap inhibitor
11/09/2006	WO2005070026A3 Drug immunoconjugate combination therapy
11/09/2006	US20060252915 Inhibit the growth of microorganisms in environments with physiological salt concentrations and at the same time have as low as possible a hemolytic activity
11/09/2006	US20060252815 Novel combination of anticholineric and beta mimetics for the treatment of respiratory diseases
11/09/2006	US20060252814 Formulation comprising a betablocker and optionally a cholestrol-lowering agent
11/09/2006	US20060252806 synergistic use of angiotensin II receptor antagonist like (5-methyl-2-oxo-1,3-dioxolen-4-yl)methyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]imidazol-5-carboxylate with the calcium channel blockers; calcium channel blockers containing 1,4-dihydropyridine group
11/09/2006	US20060252805 synergistic use of angiotensin II receptor antagonist like (5-methyl-2-oxo-1,3-dioxolen-4-yl)methyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]imidazol-5-carboxylate with the calcium channel blockers; calcium channel blockers containing 1,4-dihydropyridine group
11/09/2006	US20060252766 Methods using a combination of 3-heteroaryl-2-indolinone and a cyclooxygenase-2 inhibitor for the treatment of neoplasia
11/09/2006	US20060252764 HIV inhibiting pyrimidines derivatives
11/09/2006	US20060252762 Methods for treatment of multiple sclerosis
11/09/2006	US20060252716 Method for reversing the immunosuppressive effects of the melanoma inhibitory activity "mia"
11/09/2006	US20060252714 Pharmaceutical compositions and methods for treating multidrug resistant cancer
11/09/2006	US20060252686 Combinations of chromium or vanadium with antidiabetics for glucose metabolism disorders
11/09/2006	US20060252157 Larynx carcinoma-associated protein larcap-1
11/09/2006	US20060252104 Screening for a compound to inhibit the urge for urinary incontinence by detecting activation of KCNQ protein in the host cell; measuring the membrane potential of the host cell and selecting the compound whose presence causes hyperpolarization in themembrane potential of the host cell
11/09/2006	US20060252036 Alteration of rab38 function to modulate mammalian pigmentation
11/09/2006	US20060252035 Using sphingosine kinase-2 as tool in identifying modulators for use in treatment of cell proliferative disorders
11/09/2006	US20060251742 CO2 extraction techniques provide reduced levels of methysticin and dihydromethysticin with increased levels of kavain and dihydrokavain; paste, powder, liquid, or rapid-dissolve tablet; enhances efficacy of a botanical extract co-ingredient
11/09/2006	US20060251738 Rock flour, especially dolomite-based medicament, for the treatment of cancer diseases
11/09/2006	US20060251731 Therapeutic herbal lozenge composition
11/09/2006	US20060251721 Hydrocodone and acetaminophen; twice-a-day administration; pain relievers
11/09/2006	US20060251715 Oral delivery of a botanical
11/09/2006	US20060251648 Nucleotide sequences coding transport protein for use in identifying modulators for treatment of pain; flavor enhancement
11/09/2006	US20060251646 Anti-tirc7 antibodies in therapy of inflammatiory diseases
11/09/2006	US20060251629 Muscle-based grafts/implants
11/09/2006	US20060251616 Migration of hematopoietic stem cells and progenitor cells to the liver
11/09/2006	US20060251589 Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory diseases
11/09/2006	US20060251588 Delivery of erectile dysfunction drugs through an inhalation route
11/09/2006	US20060251587 Delivery of analgesics through an inhalation route
11/09/2006	US20060251580 Lectin conjugates
11/09/2006	DE102005020401A1 Use of local anesthetic (from anilide groups) in the preparation of medicaments to treat diseases such as nervous system (e.g. dementia, Parkinson's disease and depression)
11/09/2006	DE102005020230A1 Verwendung von Indolin-Phenylsulfonamid-Derivaten Use of indoline derivatives phenylsulfonamide
11/09/2006	DE102005020229A1 Verwendung von Indolin-Phenylsulfonamid-Derivaten Use of indoline derivatives phenylsulfonamide
11/09/2006	CA2613169A1 Use of carotenoids and/or carotenoid derivatives/analogs for reduction/inhibition of certain negative effects of cox inhibitors
11/09/2006	CA2607772A1 Promoter for introducing extracellular substance into mammalian ovum and introduction method
11/09/2006	CA2607524A1 Agent for prophylaxis and treating of pancreatitis
11/09/2006	CA2606489A1 Method for identification of compound having antidepressant effect
11/09/2006	CA2606177A1 Novel polypeptide and use thereof
11/09/2006	CA2605773A1 Stable emulsion composition
11/09/2006	CA2604617A1 Composition containing anti-dementia drug
11/09/2006	CA2603060A1 Therapeutic agent for chronic obstructive pulmonary disease
11/08/2006	EP1719773A1 Fused heterotetracyclic compounds and use tehreof as hcv polymerase inhibitor
11/08/2006	EP1719543A1 Use of histone deacetylase inhibitors for the treatment of gastrointestinal distress
11/08/2006	EP1719526A2 Pharmaceutical combinations comprising a P2T receptor antagonist and another anti-thrombotic agent
11/08/2006	EP1719525A1 NUCLEAR TRANSFER PROMOTER FOR Cdc42 PROTEIN AND METHOD OF SCREENING THE SAME
11/08/2006	EP1719524A1 Nuclear transfer promoter for rac protein and method of screening the same
11/08/2006	EP1719518A1 Compositions comprising bacillus coagulans for increasing the solubility and bioavailability of nutritional minerals
11/08/2006	EP1719515A2 Glycyrrhizin or derivatives thereof for treating or preventing togavirus infections
11/08/2006	EP1719511A2 N-[4-(4-amino-2-ethyl-1H-imidazo[4,5-c]quinolin-1-yl)butyl]methanesulfonamide, a pharmaceutical composition comprising the same and use thereof
11/08/2006	EP1719508A1 Use of histone deacetylase inhibitors for the prevention or treatment of joint destruction
11/08/2006	EP1719502A1 Composition for easing human childbirth
11/08/2006	EP1719496A2 Method for producing purified hematinic iron-saccharidic complex and product produced
11/08/2006	EP1719495A2 Method for producing purified hematinic iron-saccharidic complex and product produced
11/08/2006	EP1718641A2 Benzimidazole derivative and its use as aii receptor antagonist
11/08/2006	EP1718635A1 Piperidinyl targeting compounds that selectively bind integrins
11/08/2006	EP1718568A2 Process for preparing water soluble diterpenes and their applications
11/08/2006	EP1718337A1 New combinations of an anti emetic agent and an enkephalinase inhibitor
11/08/2006	EP1718336A2 Novel combination of anticholinergic and beta mimetics for the treatment of respiratory diseases
11/08/2006	EP1718330A2 Complexed polypeptide and adjuvant for improved vaccines
11/08/2006	EP1718326A2 New pharmaceutical compositions based on benzilic acid esters and soluble tnf receptor fusion proteins
11/08/2006	EP1718312A2 Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines
11/08/2006	EP1718311A1 Therapeutic combinations of atypical antipsychotics with corticotropin releasing factor antagonists
11/08/2006	EP1718309A2 Anorectic compounds
11/08/2006	EP1718303A2 Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory agent
11/08/2006	EP1718301A1 Pharmaceutical compositions based on anticholinergics and pegsunercept
11/08/2006	EP1718296A2 Use of metronidazole for preparing a pharmaceutical composition for treating pathologies related to the b-type receptor of interleukin 8 and/or to a pacap type 1 receptor
11/08/2006	EP1718295A2 Use of metronidazole for preparing a pharmaceutical composition for treating a cutaneous inflammation
11/08/2006	EP1718291A1 Use of cholinesterase inhibitors for treating vascular depression
11/08/2006	EP1718284A2 Susceptibility gene for myocardial infraction, stroke, and paod; methods of treatment
11/08/2006	EP1718266A2 Canine probiotic bifidobacteria pseudolongum

1 ... 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 ... 1151